Lensar (LNSR) EBIT Growth (3y) (2022 - 2026)
Lensar (LNSR) EBIT Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 13.06% |
| 10 | Lensar | 101.45 Mn | 87.89 Mn | 9.78 Mn | 40.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.01% |
| Mar 31, 2026 | 35.96% |
| Dec 31, 2025 | -23.48% |
| Sep 30, 2025 | -22.90% |
| Jun 30, 2025 | 2.56% |
| Mar 31, 2025 | 4.67% |
| Dec 31, 2024 | 30.91% |
| Sep 30, 2024 | 41.33% |
| Jun 30, 2024 | -6.47% |
| Mar 31, 2024 | 18.16% |
| Dec 31, 2023 | 24.38% |
| Sep 30, 2023 | 24.35% |
| Jun 30, 2023 | 9.30% |
| Mar 31, 2023 | -12.06% |
| Dec 31, 2022 | -10.61% |
| Sep 30, 2022 | 8.54% |